Competition delays multi-drug resistance evolution during combination therapy
نویسندگان
چکیده
منابع مشابه
Combination drugs therapy delays diabetic induced cognitive impairment
p.p1 {margin: 0.0px 0.0px 10.0px 0.0px; font: 10.0px 'Times New Roman'; color: #000000; -webkit-text-stroke: #000000} span.s1 {font-kerning: none} Presently drugs that are available to treat the diabetic induced cognitive impairment presents adverse effect on long term used. This study offers evidence that old drugs can be combined and used. Existing and affordable drugs can be repurposed a...
متن کاملSeeking Goldilocks During Evolution of Drug Resistance
Speciation can occur when a population is split and the resulting subpopulations evolve independently, accumulating mutations over time that make them incompatible with one another. It is thought that such incompatible mutations, known as Bateson-Dobzhansky-Muller (BDM) incompatibilities, may arise when the two populations face different environments, which impose different selective pressures....
متن کاملExploiting evolution to treat drug resistance: combination therapy and the double bind.
Although many anticancer therapies are successful in killing a large percentage of tumor cells when initially administered, the evolutionary dynamics underpinning tumor progression mean that, often, resistance is an inevitable outcome. Research in the field of ecology suggests that an evolutionary double bind could be an effective way to treat tumors. In an evolutionary double bind two therapie...
متن کاملHepatitis B Virus Drug Resistance and Combination Therapy
Despite the development of new nucleoside analogs, antiviral therapy of chronic hepatitis B remains a major clinical challenge. Indeed, because of both viral genome persistence and hepatitis B virus genome heterogeneity, these antivirals may select for drug-resistant mutants. The development of drug resistance is associated with liver disease progression. The progress made in virologic assays a...
متن کاملPrevention of viral drug resistance by novel combination therapy.
A new form of antiviral clinical therapy is proposed in which three different drugs are administered against three different targets on the same virus-coded protein. If the physiological functions of the three different target sites are not independent of each other, then a mutation conferring drug resistance at one site may alter the physiological functions at the other sites and further drug ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Theoretical Biology
سال: 2021
ISSN: 0022-5193
DOI: 10.1016/j.jtbi.2020.110524